Terol, M.; IRIM (ex-CPBS)-UMR 9004, Research Institute in Infectiology of Montpellier, University of Montpellier, Montpellier, France
Gazon, Hélène ; Université de Liège - ULiège > GIGA-R : Epigénétique Cellulaire et Moléculaire
Lemasson, I.; Brody School of Medicine, Department of Microbiology and Immunology, East Carolina University, Greenville, NC, United States
Duc-Dodon, M.; Laboratoire de Biologie et Modélisation de la Cellule, CNRS - UCBL UMR 5239, Ecole Normale Supérieure de Lyon, Lyon, France
Barbeau, B.; Université du Québec à Montréal, Département des sciences biologiques, Centre de recherche BioMed, Montréal, QC, Canada
Césaire, R.; Laboratoire de Virologie-Immunologie JE2503, Centre Hospitalier et Universitaire de Martinique, Fort de France Martinique, Martinique, France
Mesnard, J.-M.; IRIM (ex-CPBS)-UMR 9004, Research Institute in Infectiology of Montpellier, University of Montpellier, Montpellier, France
Péloponèse, J.-M.; IRIM (ex-CPBS)-UMR 9004, Research Institute in Infectiology of Montpellier, University of Montpellier, Montpellier, France
Language :
English
Title :
HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression
Gallo RC. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2005; 2: 17
Takatsuki K. Discovery of adult T-cell leukemia. Retrovirology 2005; 2: 16
Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79: 428-437
Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 2003; 17: 26-38
Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007; 7: 270-280
Peloponese JM, Yeung ML, Jeang KT. Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res 2006; 34: 1-12
Enose-Akahata Y, Abrams A, Johnson KR, Maloney EM, Jacobson S. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica. Blood 2012; 119: 2829-2836
Kannian P, Yin H, Doueiri R, Lairmore MD, Fernandez S, Green PL. Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion. J Virol 2012; 86: 3757-3766
Satou Y, Yasunaga J-I, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA 2006; 103: 720-725
Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer 2004; 20: 559-567
Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008; 112: 3788-3797
Gazon H, Lemasson I, Polakowski N, Cesaire R, Matsuoka M, Barbeau B, et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3' long terminal repeat. J Virol 2012; 86: 9070-9078
Landry S, Halin M, Vargas A, Lemasson I, Mesnard JM, Barbeau B. Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein. J Virol 2009; 83: 2048-2054
Yoshida M, Satou Y, Yasunaga J, Fujisawa J-I, Matsuoka M. Transcriptional control of spliced and unspliced HTLV-1 bZIP factor gene. J Virol 2008; 82: 9359-9368
Koiwa T, Hamano-Usami A, Ishida T, Okayama A, Yamaguchi K, Kamahira S, et al. 5'-Long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type I provirus in vitro and in vivo. J Virol 2002; 76: 9389-9397
Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM. The complementary strand of HTLV-1 RNA genome encodes a bZIP transcription factor that down-regulates the viral transcription. J Virol 2002; 76: 12813-12822
Hivin P, Arpin-André C, Clerc I, Barbeau B, Mesnard JM. A modified version of a Fos-associated cluster in HBZ affects Jun transcriptional potency. Nucleic Acids Res 2006; 34: 2761-2772
Clerc I, Polakowski N, Andre-Arpin C, Cook P, Barbeau B, Mesnard J-M, et al. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ. J Biol Chem 2008; 283: 23903-23913
Hivin P, Frédéric M, Arpin-André C, Basbous J, Gay B, Thébault S, et al. Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs. J Cell Sci 2005; 118: 1355-1362
Lemasson I, Lewis MR, Polakowski N, Hivin P, Cavanagh MH, Thebault S, et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 2007; 81: 1543-1553
Hagiya K, Yasunaga J, Satou Y, Ohshima K, Matsuoka M. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology 2011; 8: 19
Zhao T, Coutts A, Xu L, Yu J, Ohshima K, Matsuoka M. HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPalpha signaling. Retrovirology 2013; 10: 159
Reinke AW, Grigoryan G, Keating AE. Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays. Biochemistry 2010; 49: 1985-1997
Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM. HBZ factor of HTLV-I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem 2003; 278: 43620-43627
Hivin P, Basbous J, Raymond F, Henaff D, Arpin-Andre C, Robert-Hebmann V, et al. The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies. Retrovirology 2007; 4: 14
Thébault S, Basbous J, Hivin P, Devaux C, Mesnard JM. HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett 2004; 562: 165-170
Kuhlmann AS, Villaudy J, Gazzolo L, Castellazzi M, Mesnard JM, Duc Dodon M, HTLV-1 HBZ. cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology 2007; 4: 92
Hernandez JM, Floyd DH, Weilbaecher KN, Green PL, Boris-Lawrie K. Multiple facets of junD gene expression are atypical among AP-1 family members. Oncogene 2008; 27: 4757-4767
Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 1994; 76: 747-760
Mori N, Fujii M, Iwai K, Ikeda S, Yamasaki Y, Hata T, et al. Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells. Blood 2000; 95: 3915-3921
Barbeau B, Mesnard JM. Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia? Int Rev Immunol 2007; 26: 283-304
Belrose G, Gross A, Olindo S, Lezin A, Dueymes M, Komla-Soukha I, et al. Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. Blood 2011; 118: 2483-2491
Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature 2012; 489: 101-108
Ke N, Albers A, Claassen G, Yu DH, Chatterton JE, Hu X, et al. One-week 96-well soft agar growth assay for cancer target validation. BioTechniques 2004; 36: 826-828, 830, 832-823
Schneider CA, Rasband WS, Eliceiri KW. NIH: Imageto ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-675
Gazon H, Belrose G, Terol M, Meniane JC, Mesnard JM, Cesaire R, et al. Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients. Oncotarget 2016; 7: 30258-30275
Nakatani Y, Ogryzko V. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol 2003; 370: 430-444
Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, et al. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474: 654-657
Barbeau B, Mesnard JM. Making sense out of antisense transcription in human T-cell lymphotropic viruses (HTLVs). Viruses 2011; 3: 456-468
Belrose G, Gross A, Olindo S, Lezin A, Dueymes M, Komla-Soukha I, et al. Opposite effects of valproate on Tax and HBZ expressions in T-lymphocytes from HTLV-1 asymptomatic carriers and HAM/TSP patients. Blood 2011; 118: 2483-2491
Shuh M, Hill SA, Derse D. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses. Virology 1999; 262: 442-451
Shiohama Y, Naito T, Matsuzaki T, Tanaka R, Tomoyose T, Takashima H, et al. Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status. Retrovirology 2016; 13: 29
Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N, et al. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 1991; 6: 1023-1029
Agarwal SK, Novotny EA, Crabtree JS, Weitzman JB, Yaniv M, Burns AL, et al. Transcription factor Jun D, deprived of menin, switches from growth suppressor to growth promoter. Proc Natl Acad Sci USA 2003; 100: 10770-10775
Risser R, Pollack R. A nonselective analysis of SV40 transformation of mouse 3T3 cells. Virology 1974; 59: 477-489
Enose-Akahata Y, Caruso B, Haner B, Charlip E, Nair G, Massoud R, et al. Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1). Retrovirology 2016; 13: 56
Vandamme AM, Salemi M, Desmyter J. The simian origins of the pathogenic human T-cell lymphotropic virus type I. Trends Microbiol 1998; 6: 477-483
Wethmar K, Smink JJ, Leutz A. Upstream open reading frames: molecular switches in (patho)physiology. BioEssays 2010; 32: 885-893
Mauro VP, Chappell SA, Dresios J. Analysis of ribosomal shunting during translation initiation in eukaryotic mRNAs. Methods Enzymol 2007; 429: 323-354
Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003; 3: 179-192
Stumpf CR, Ruggero D. The cancerous translation apparatus. Curr Opin Genet Dev 2011; 21: 474-483
Adilakshmi T, Laine RO. Ribosomal protein S25 mRNA partners with MTF-1 and La to provide a p53-mediated mechanism for survival or death. J Biol Chem 2002; 277: 4147-4151
Zhang X, Wang W, Wang H, Wang MH, Xu W, Zhang R. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop. Oncogene 2013; 32: 2782-2791
Laine RO, Shay NF, Kilberg MS. Nuclear retention of the induced mRNA following amino acid-dependent transcriptional regulation of mammalian ribosomal proteins L17 and S25. J Biol Chem 1994; 269: 9693-9697
Kim H, Lee JE, Cho EJ, Liu JO, Youn HD. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res 2003; 63: 6135-6139
Short JD, Pfarr CM. Translational regulation of the JunD messenger RNA. J Biol Chem 2002; 277: 32697-32705
Borowiak M, Kuhlmann AS, Girard S, Gazzolo L, Mesnard JM, Jalinot P, et al. HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene. Carcinogenesis 2013; 34: 2664-2672
de Wilde J, De-Castro Arce J, Snijders PJ, Meijer CJ, Rosl F, Steenbergen RD. Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol 2008; 30: 77-87
Barbosa C, Peixeiro I, Romao L. Gene expression regulation by upstream open reading frames and human disease. PLoS Genet 2013; 9: e1003529
Mesnard JM, Barbeau B, Cesaire R, Peloponese JM. Roles of HTLV-1 basic zip factor (HBZ) in viral chronicity and leukemic transformation. potential new therapeutic approaches to prevent and treat HTLV-1-related diseases. Viruses 2015; 7: 6490-6505
Hertz MI, Landry DM, Willis AE, Luo G, Thompson SR. Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting. Mol Cell Biol 2013; 33: 1016-1026